Health Forums

Full Version: Schering-Plough, Merck's Vytorin misses study goal (AP)
You're currently viewing a stripped down version of our content. View the full version with proper formatting.
AP - In the latest disappointment for cholesterol pill Vytorin, a major European study in patients with heart valve disease found the drug didn't prevent worsening of the disease or lower the need for valve surgery, sending its makers' stock plunging.

Posted on Mon, 21 Jul 2008 21:34:37 GMT at http://us.rd.yahoo.com/dailynews/rss/hea...ng_vytorin
Reference URL's

Fatal error: Cannot redeclare class databaseEngine in /home/jsporri/public_html/healthau.net/forum/inc/db_mysqli.php on line 13